CEO, CSO – Dr. Heikki Lanckriet, PhD
Heikki Lanckriet (PhD) has developed broad expertise and commercial experience in the Life Science Tools and Reagents area. In 2003, whilst at Cambridge University, Heikki co-founded Expedeon. He accumulated a deep knowledge of the many facets of business by evolving through the roles of COO, CSO and CEO at Expedeon.
Heikki has a passion for science and innovation with strong sense of commercial pragmatism. He holds a Bachelor’s and Master’s degree in Biochemical Engineering from the University of Ghent, Belgium and a PhD in Biochemical Engineering from the University of Cambridge, UK.
He has published papers in high impact peer-reviewed international scientific journals and is named inventor on a multitude of patents.
CFO, David Roth
David has over 20 years’ experience in and audit and accounting, with special focus in the healthcare sector. He is a chartered accountant having worked with KPMG, Deloitte and Arthur Andersen in the U.K., where he became a director and partner within the audit and advisory practice. Here he acted for a wide range of clients which included biotech as well as advising listed companies both in the UK and the US.
More recently he has worked as CFO in several multi location organizations, all of them in high growth healthcare businesses, leading financial and operational teams. This included reporting accountant on a $100m secondary NASDAQ listing and subsequent reporting roles, as well as analysis and financial support in several business acquisition and corporate transactions.
David is a German national living in the U.K.; he graduated from the University of Hertfordshire where he studied business.